Global Pharmaceuticals & Biotech Large Cap High Growth Potential

Ascendis Pharma

Market Cap: US$10.7b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Alnylam Pharmaceuticals

Market Cap: US$42.3b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

ALTEOGEN

Market Cap: ₩22.4t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Akeso

Market Cap: HK$98.6b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

Exelixis

Market Cap: US$12.0b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Insmed

Market Cap: US$18.4b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Beijing Wantai Biological Pharmacy Enterprise

Market Cap: CN¥75.8b

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

argenx

Market Cap: €28.4b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Vertex Pharmaceuticals

Market Cap: US$118.0b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

Eli Lilly

Market Cap: US$693.8b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

BeOne Medicines

Market Cap: US$28.5b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Sandoz Group

Market Cap: CHF 19.0b

Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

GSK

Market Cap: UK£57.2b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Illumina

Market Cap: US$15.4b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

AstraZeneca

Market Cap: UK£160.3b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Innovent Biologics

Market Cap: HK$140.8b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.

Daiichi Sankyo Company

Market Cap: JP¥5.9t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

AbbVie

Market Cap: US$331.4b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

Galderma Group

Market Cap: CHF 29.6b

Operates as a dermatology company worldwide.

Orion Oyj

Market Cap: €9.2b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Sartorius Stedim Biotech

Market Cap: €19.6b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

Incyte

Market Cap: US$13.0b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Neurocrine Biosciences

Market Cap: US$12.7b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

Celltrion

Market Cap: ₩38.8t

A biopharmaceutical company, engages in the development, production, and sale of various therapeutic proteins for the treatment of oncology diseases.

Teva Pharmaceutical Industries

Market Cap: US$19.3b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Lonza Group

Market Cap: CHF 39.2b

Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.

Novo Nordisk

Market Cap: DKK 2.0t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Torrent Pharmaceuticals

Market Cap: ₹1.1t

Engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.

Natera

Market Cap: US$21.7b

A diagnostics company, provides molecular testing services worldwide.

Recordati Industria Chimica e Farmaceutica

Market Cap: €11.0b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

Takeda Pharmaceutical

Market Cap: JP¥6.9t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

Qiagen

Market Cap: US$10.3b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Viatris

Market Cap: US$10.8b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Tempus AI

Market Cap: US$10.1b

Operates as a healthcare technology company.

Sino Biopharmaceutical

Market Cap: HK$96.0b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

Roche Holding

Market Cap: CHF 206.6b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.